Home › Funds › Tweedy, Browne Co LLC › GSK

Tweedy, Browne Co LLC position in GSK

GSK PLC · Health Care

Tweedy, Browne Co LLC reported holding 77,439 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$3.7M, representing 0.30% of its reported portfolio and ranking #33 among its reported holdings. Tweedy, Browne Co LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)77.44K sh
Reported value held$3.73M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tweedy, Browne Co LLC's GSK position evolved

Tweedy, Browne Co LLC first disclosed a stake in GSK in Q3 2023 at 129,994 shares (US$4.7M). The position peaked in Q1 2024 at 123,044 shares, worth US$5.3M. Across 13 filings, Tweedy, Browne Co LLC increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 77,439 shares valued at US$3.7M — a reduction of -4,088 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 129.99K $4.71M New
Q4 2023 124.40K $4.61M Reduce
Q1 2024 123.04K $5.27M Reduce
Q2 2024 109.86K $4.23M Reduce
Q3 2024 108.03K $4.42M Reduce
Q4 2024 93.82K $3.17M Reduce
Q1 2025 90.55K $3.51M Reduce
Q2 2025 86.87K $3.34M Reduce
Q3 2025 82.24K $3.55M Reduce
Q4 2025 82.24K $4.03M Hold
Q1 2026 81.78K $4.51M Reduce
Q2 2026 81.53K $4.27M Hold
Q3 2026 77.44K $3.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has Tweedy, Browne Co LLC held GSK?

Tweedy, Browne Co LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tweedy, Browne Co LLC's current position in GSK?

As of Q3 2026, Tweedy, Browne Co LLC holds 77.44K shares of GSK (GSK PLC), valued at $3.73M, representing 0.30% of its reported portfolio and ranking #33.

Has Tweedy, Browne Co LLC been buying or selling GSK?

In the latest 13F filing (Q3 2026), Tweedy, Browne Co LLC reduced its position in GSK. The position peaked in Q1 2024 at 123.04K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.